23.02.2013 Views

LabAutomation 2006 - SLAS

LabAutomation 2006 - SLAS

LabAutomation 2006 - SLAS

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

TP07<br />

Anne T. Ferguson<br />

MDS Sciex<br />

Sunnyvale, California<br />

anne.ferguson@sciex.com<br />

Where Laboratory Technologies Emerge and Merge<br />

Co-Author(s):<br />

Debra Gallant<br />

Ryan McGuinness<br />

Gordon Leung<br />

MDS Sciex<br />

Yuanping Wang<br />

Lisa Minor<br />

Jenson Qi<br />

Johnson & Johnson, PRD<br />

Development of a Label-Free Cellular Assay for an Endogenously-Expressed GPCR<br />

Using Cellular Dielectric Spectroscopy<br />

Cell based assays for drug discovery offer advantages over molecular approaches by providing more complex data in a living cell state.<br />

Additionally, screening receptor targets in the endogenous setting provides data that is more physiologically relevant with less effort than<br />

transfected and cloned cell lines. Using CDS, a label-free cellular assay, we analyzed the activation of an important GPCR expressed<br />

endogenously in two related rhabdomyosarcoma cell lines. It is important to note that CDS was capable of measuring cellular responses<br />

to ligand addition where Ca2+ assays were not. Both a receptor agonist and antagonist were evaluated and EC50 and IC50 values were<br />

derived. Receptor specificity was also demonstrated by effectively blocking the cellular responses to agonist after antagonist pre-treatment.<br />

This novel and simplified approach enabled the development of a physiologically relevant cellular assay that is useful in drug discovery<br />

applications.<br />

TP08<br />

Igor Fomenko<br />

Amgen<br />

Newbury Park, California<br />

ifomenko@amgen.com<br />

Co-Author(s)<br />

Bahram G. Kermani, Illumina<br />

Theo Kotseroglou<br />

Behrouz Forood<br />

Lori Clark<br />

David Barker<br />

Michal Lebl<br />

Illumina<br />

Decoding Beads in a Randomly-Assembled Optical Nose<br />

In Illumina’s technology, the term bead is synonymous with microsensors used in optical arrays. Unlike orderly arranged microarrays, a<br />

randomly-assembled array would need to be processed via a so-called decoding step, in order to identify the location of each beadtype.<br />

Illumina’s O-Nose technology is radically different from the electronic nose (E-Nose) technologies by several factors, e.g., the number of<br />

sensors. In an O-Nose application, one can easily obtain 2000 usable sensors. The quantity of sensors, however, does come at a price,<br />

i.e., the necessity for a decoding procedure. The decoding step plays a challenging role in the O-Nose technology. A novel supervised<br />

learning technique of decoding randomly-assembled arrays, based on subspace classifier method is proposed.<br />

155

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!